Analysis

Vir Biotechnology, Inc. (VIR) Stock Analysis

Vir Biotechnology, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to VIR.

websiteVIR/analysis/VIR

Vir Biotechnology, Inc.

Vir Biotechnology, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to VIR.

Stock profile

Ticker

VIR

Asset type

Stock

Market cap

$1.45B

Sector

Health Technology

Industry

Biotechnology

Currency

USD

Ticker listings

Vir Biotechnology, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • VIR primary listing

Latest Vir Biotechnology, Inc. news

Vir Biotechnology Announces Appointment of Timothy Coughlin to its Board of Directors

Vir Biotechnology Announces Appointment of Timothy Coughlin to its Board of

Vir Biotechnology to Present Complete Week 96 Data from Phase 2 SOLSTICE Clinical Trial in Hepatitis Delta at the European Association fo...

SAN FRANCISCO, May 18, 2026--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will present data from the Phase 2 SOLSTICE trial evaluating the combination of to...

Sotrovimab (Xevudy: Vir Biotechnology, GlaxoSmithKline) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecast...

Key market opportunities for Sotrovimab (Xevudy) include increased prevalence of COVID-19, necessitating early-stage treatment and high-risk patient protection; rising healthcar...

Vir Biotechnology Provides Corporate Update and Reports First Quarter 2026 Financial Results

SAN FRANCISCO, May 06, 2026--Vir Biotechnology, Inc. (Nasdaq: VIR), today provided a corporate update and reported financial results for the first quarter ended March 31, 2026.

Vir Biotechnology to Participate in Bank of America Securities 2026 Healthcare Conference

SAN FRANCISCO, May 05, 2026--Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, will participate in a fi...

Research sections

Valuation

Review valuation context for Vir Biotechnology, Inc..

Future growth

Review future growth context for Vir Biotechnology, Inc..

Past performance

Review past performance context for Vir Biotechnology, Inc..

Financial health

Review financial health context for Vir Biotechnology, Inc..

Dividend

Review dividend context for Vir Biotechnology, Inc..

Management

Review management context for Vir Biotechnology, Inc..

Ownership

Review ownership context for Vir Biotechnology, Inc..

Other information

Review other information context for Vir Biotechnology, Inc..

Community

Review community context for Vir Biotechnology, Inc..